Unique effects of carvedilol on noradrenaline release in the human heart

European Journal of Heart Failure

Volumn 4, Issue 2, 2002, Pages 147-149

  Richardt, G ^a   Richardt, D ^a   Adler, S ^a   Kraatz, E ^a   Notzold A ^a   Kurz, T ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BISOPROLOL; CARVEDILOL; METOPROLOL; NORADRENALIN;

ADRENERGIC TRANSMISSION; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CONTROLLED STUDY; DRUG EFFICACY; ELECTROCHEMICAL DETECTION; ELECTROSTIMULATION; HEART ATRIUM; HEART FAILURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; NORADRENALIN RELEASE; PRIORITY JOURNAL;

ADRENERGIC BETA-ANTAGONISTS; BISOPROLOL; CARBAZOLES; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART; HEART FAILURE, CONGESTIVE; HUMANS; METOPROLOL; MYOCARDIUM; NOREPINEPHRINE; PROPANOLAMINES; TREATMENT OUTCOME;

EID: 0036119922     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-9842(01)00220-3     Document Type: Article

References (5)

1. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: The CAPRICORN randomised trial
2. Effect of carvedilol on survival in severe chronic heart failure
3. Adverse consequences of high sympathetic nerve activity in the failing human heart
4. Differential effects of carvedilol on norepinephrine release in normoxic and ischemic heart
5. Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart